Cargando…

Modeling and Cost Benefit Analysis to Guide Deployment of POC Diagnostics for Non-typhoidal Salmonella Infections with Antimicrobial Resistance

Invasive non-typhoidal Salmonella (NTS) is among the leading causes of blood stream infections in sub-Saharan Africa and other developing regions, especially among pediatric populations. Invasive NTS can be difficult to treat and have high case-fatality rates, in part due to emergence of strains res...

Descripción completa

Detalles Bibliográficos
Autores principales: Manore, Carrie, Graham, Todd, Carr, Alexa, Feryn, Alicia, Jakhar, Shailja, Mukundan, Harshini, Highlander, Hannah Callender
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677775/
https://www.ncbi.nlm.nih.gov/pubmed/31375759
http://dx.doi.org/10.1038/s41598-019-47359-2
_version_ 1783440953387778048
author Manore, Carrie
Graham, Todd
Carr, Alexa
Feryn, Alicia
Jakhar, Shailja
Mukundan, Harshini
Highlander, Hannah Callender
author_facet Manore, Carrie
Graham, Todd
Carr, Alexa
Feryn, Alicia
Jakhar, Shailja
Mukundan, Harshini
Highlander, Hannah Callender
author_sort Manore, Carrie
collection PubMed
description Invasive non-typhoidal Salmonella (NTS) is among the leading causes of blood stream infections in sub-Saharan Africa and other developing regions, especially among pediatric populations. Invasive NTS can be difficult to treat and have high case-fatality rates, in part due to emergence of strains resistant to broad-spectrum antibiotics. Furthermore, improper treatment contributes to increased antibiotic resistance and death. Point of care (POC) diagnostic tests that rapidly identify invasive NTS infection, and differentiate between resistant and non-resistant strains, may greatly improve patient outcomes and decrease resistance at the community level. Here we present for the first time a model for NTS dynamics in high risk populations that can analyze the potential advantages and disadvantages of four strategies involving POC diagnostic deployment, and the resulting impact on antimicrobial treatment for patients. Our analysis strongly supports the use of POC diagnostics coupled with targeted antibiotic use for patients upon arrival in the clinic for optimal patient and public health outcomes. We show that even the use of imperfect POC diagnostics can significantly reduce total costs and number of deaths, provided that the diagnostic gives results quickly enough that patients are likely to return or stay to receive targeted treatment.
format Online
Article
Text
id pubmed-6677775
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-66777752019-08-08 Modeling and Cost Benefit Analysis to Guide Deployment of POC Diagnostics for Non-typhoidal Salmonella Infections with Antimicrobial Resistance Manore, Carrie Graham, Todd Carr, Alexa Feryn, Alicia Jakhar, Shailja Mukundan, Harshini Highlander, Hannah Callender Sci Rep Article Invasive non-typhoidal Salmonella (NTS) is among the leading causes of blood stream infections in sub-Saharan Africa and other developing regions, especially among pediatric populations. Invasive NTS can be difficult to treat and have high case-fatality rates, in part due to emergence of strains resistant to broad-spectrum antibiotics. Furthermore, improper treatment contributes to increased antibiotic resistance and death. Point of care (POC) diagnostic tests that rapidly identify invasive NTS infection, and differentiate between resistant and non-resistant strains, may greatly improve patient outcomes and decrease resistance at the community level. Here we present for the first time a model for NTS dynamics in high risk populations that can analyze the potential advantages and disadvantages of four strategies involving POC diagnostic deployment, and the resulting impact on antimicrobial treatment for patients. Our analysis strongly supports the use of POC diagnostics coupled with targeted antibiotic use for patients upon arrival in the clinic for optimal patient and public health outcomes. We show that even the use of imperfect POC diagnostics can significantly reduce total costs and number of deaths, provided that the diagnostic gives results quickly enough that patients are likely to return or stay to receive targeted treatment. Nature Publishing Group UK 2019-08-02 /pmc/articles/PMC6677775/ /pubmed/31375759 http://dx.doi.org/10.1038/s41598-019-47359-2 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Manore, Carrie
Graham, Todd
Carr, Alexa
Feryn, Alicia
Jakhar, Shailja
Mukundan, Harshini
Highlander, Hannah Callender
Modeling and Cost Benefit Analysis to Guide Deployment of POC Diagnostics for Non-typhoidal Salmonella Infections with Antimicrobial Resistance
title Modeling and Cost Benefit Analysis to Guide Deployment of POC Diagnostics for Non-typhoidal Salmonella Infections with Antimicrobial Resistance
title_full Modeling and Cost Benefit Analysis to Guide Deployment of POC Diagnostics for Non-typhoidal Salmonella Infections with Antimicrobial Resistance
title_fullStr Modeling and Cost Benefit Analysis to Guide Deployment of POC Diagnostics for Non-typhoidal Salmonella Infections with Antimicrobial Resistance
title_full_unstemmed Modeling and Cost Benefit Analysis to Guide Deployment of POC Diagnostics for Non-typhoidal Salmonella Infections with Antimicrobial Resistance
title_short Modeling and Cost Benefit Analysis to Guide Deployment of POC Diagnostics for Non-typhoidal Salmonella Infections with Antimicrobial Resistance
title_sort modeling and cost benefit analysis to guide deployment of poc diagnostics for non-typhoidal salmonella infections with antimicrobial resistance
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677775/
https://www.ncbi.nlm.nih.gov/pubmed/31375759
http://dx.doi.org/10.1038/s41598-019-47359-2
work_keys_str_mv AT manorecarrie modelingandcostbenefitanalysistoguidedeploymentofpocdiagnosticsfornontyphoidalsalmonellainfectionswithantimicrobialresistance
AT grahamtodd modelingandcostbenefitanalysistoguidedeploymentofpocdiagnosticsfornontyphoidalsalmonellainfectionswithantimicrobialresistance
AT carralexa modelingandcostbenefitanalysistoguidedeploymentofpocdiagnosticsfornontyphoidalsalmonellainfectionswithantimicrobialresistance
AT ferynalicia modelingandcostbenefitanalysistoguidedeploymentofpocdiagnosticsfornontyphoidalsalmonellainfectionswithantimicrobialresistance
AT jakharshailja modelingandcostbenefitanalysistoguidedeploymentofpocdiagnosticsfornontyphoidalsalmonellainfectionswithantimicrobialresistance
AT mukundanharshini modelingandcostbenefitanalysistoguidedeploymentofpocdiagnosticsfornontyphoidalsalmonellainfectionswithantimicrobialresistance
AT highlanderhannahcallender modelingandcostbenefitanalysistoguidedeploymentofpocdiagnosticsfornontyphoidalsalmonellainfectionswithantimicrobialresistance